BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16200633)

  • 21. Deep venous thrombosis in children and adolescents.
    Levy ML; Granville RC; Hart D; Meltzer H
    J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC; Devidas M; Lauer SJ; Billett A; Marymont M; Pullen J; Camitta B; Winick N; Carroll W; Ritchey AK
    J Clin Oncol; 2006 Jul; 24(19):3142-9. PubMed ID: 16809737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of venous access device wound complications in patients undergoing paclitaxel chemotherapy for gynecologic malignancies.
    Boulay RM; Olt GJ; Podczaski ES
    Gynecol Oncol; 1998 Aug; 70(2):259-62. PubMed ID: 9740701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exclusion of neutropenic children from implanted central venous catheter placement: impact on early catheter removal.
    Gutierrez I; Gollin G
    J Pediatr Surg; 2010 Jun; 45(6):1115-9. PubMed ID: 20620305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
    Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
    Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
    Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
    Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Convulsions during treatment of acute lymphoblastic leukemia in children].
    Mainero G; Barisone E; Boffi P; Farinasso L; Landolfi C; Dalponte S; Sicca E; Papalla F; Miniero R; Madon E
    Minerva Pediatr; 2000 Apr; 52(4):205-14. PubMed ID: 11995204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenic rupture in children with hematologic malignancies.
    Athale UH; Kaste SC; Bodner SM; Ribeiro RC
    Cancer; 2000 Jan; 88(2):480-90. PubMed ID: 10640983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia.
    Roberson JR; Raju S; Shelso J; Pui CH; Howard SC
    Pediatr Blood Cancer; 2008 Jun; 50(6):1207-12. PubMed ID: 18266226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia.
    Almuneef MA; Memish ZA; Balkhy HH; Hijazi O; Cunningham G; Francis C
    J Hosp Infect; 2006 Feb; 62(2):207-13. PubMed ID: 16307822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
    Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
    Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
    De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
    Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Klimza MJ; Sońta-Jakimczyk DJ
    Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.
    ; te Loo DM; Kamps WA; van der Does-van den Berg A; van Wering ER; de Graaf SS
    J Clin Oncol; 2006 May; 24(15):2332-6. PubMed ID: 16710032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin and soft tissue complications in pediatric leukemia patients with and without central venous catheters.
    Demircioğlu F; Ylmaz S; Oren H; Ozgüven AA; Irken G
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):32-5. PubMed ID: 18176177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central venous access ports in children treated for hematopoietic malignancies.
    Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
    Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.